Cargando…
The severe COVID-19: A sepsis induced by viral infection? And its immunomodulatory therapy
COVID-19 is known for its magical infectivity, fast transmission and high death toll based on the large number of infected people. From the perspective of the clinical manifestation, autopsy examination and pathophysiology, the essence of COVID-19 should be viewed as a sepsis induced by viral infect...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7451584/ https://www.ncbi.nlm.nih.gov/pubmed/32690231 http://dx.doi.org/10.1016/j.cjtee.2020.06.002 |
_version_ | 1783575008581255168 |
---|---|
author | Lin, Hong-Yuan |
author_facet | Lin, Hong-Yuan |
author_sort | Lin, Hong-Yuan |
collection | PubMed |
description | COVID-19 is known for its magical infectivity, fast transmission and high death toll based on the large number of infected people. From the perspective of the clinical manifestation, autopsy examination and pathophysiology, the essence of COVID-19 should be viewed as a sepsis induced by viral infection, and has the essential characteristics as sepsis induced by other pathogens. Therefore, in addition to etiological and supportive treatment, immunomodulatory therapy is also appropriate to severe COVID-19. Although there is still a lack of consensus on immunotherapy for sepsis so far, relatively rich experiences have been accumulated in the past decades, which will help us in the treatment of severe COVID-19. This article will elaborate immunotherapy of sepsis, though it may not be consistent. |
format | Online Article Text |
id | pubmed-7451584 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-74515842020-08-31 The severe COVID-19: A sepsis induced by viral infection? And its immunomodulatory therapy Lin, Hong-Yuan Chin J Traumatol Special Topic on Critical Care in COVID-19 COVID-19 is known for its magical infectivity, fast transmission and high death toll based on the large number of infected people. From the perspective of the clinical manifestation, autopsy examination and pathophysiology, the essence of COVID-19 should be viewed as a sepsis induced by viral infection, and has the essential characteristics as sepsis induced by other pathogens. Therefore, in addition to etiological and supportive treatment, immunomodulatory therapy is also appropriate to severe COVID-19. Although there is still a lack of consensus on immunotherapy for sepsis so far, relatively rich experiences have been accumulated in the past decades, which will help us in the treatment of severe COVID-19. This article will elaborate immunotherapy of sepsis, though it may not be consistent. Elsevier 2020-08 2020-06-15 /pmc/articles/PMC7451584/ /pubmed/32690231 http://dx.doi.org/10.1016/j.cjtee.2020.06.002 Text en © 2020 Production and hosting by Elsevier B.V. on behalf of Chinese Medical Association. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Special Topic on Critical Care in COVID-19 Lin, Hong-Yuan The severe COVID-19: A sepsis induced by viral infection? And its immunomodulatory therapy |
title | The severe COVID-19: A sepsis induced by viral infection? And its immunomodulatory therapy |
title_full | The severe COVID-19: A sepsis induced by viral infection? And its immunomodulatory therapy |
title_fullStr | The severe COVID-19: A sepsis induced by viral infection? And its immunomodulatory therapy |
title_full_unstemmed | The severe COVID-19: A sepsis induced by viral infection? And its immunomodulatory therapy |
title_short | The severe COVID-19: A sepsis induced by viral infection? And its immunomodulatory therapy |
title_sort | severe covid-19: a sepsis induced by viral infection? and its immunomodulatory therapy |
topic | Special Topic on Critical Care in COVID-19 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7451584/ https://www.ncbi.nlm.nih.gov/pubmed/32690231 http://dx.doi.org/10.1016/j.cjtee.2020.06.002 |
work_keys_str_mv | AT linhongyuan theseverecovid19asepsisinducedbyviralinfectionanditsimmunomodulatorytherapy AT linhongyuan severecovid19asepsisinducedbyviralinfectionanditsimmunomodulatorytherapy |